Cambridge Investment Research Advisors Inc. Sells 1,575 Shares of Aehr Test Systems (NASDAQ:AEHR)

Cambridge Investment Research Advisors Inc. reduced its position in shares of Aehr Test Systems (NASDAQ:AEHR) by 5.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,002 shares of the semiconductor company’s stock after selling 1,575 shares during the period. Cambridge Investment Research Advisors Inc. owned approximately 0.09% of Aehr Test Systems worth $190,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State of Wyoming acquired a new position in Aehr Test Systems during the 4th quarter worth approximately $67,000. Headlands Technologies LLC acquired a new position in shares of Aehr Test Systems during the fourth quarter worth $103,000. GAMMA Investing LLC lifted its stake in shares of Aehr Test Systems by 1,753.1% in the 1st quarter. GAMMA Investing LLC now owns 7,079 shares of the semiconductor company’s stock valued at $52,000 after acquiring an additional 6,697 shares during the last quarter. Mariner LLC acquired a new stake in shares of Aehr Test Systems during the 4th quarter valued at $180,000. Finally, Bayesian Capital Management LP bought a new stake in Aehr Test Systems during the 4th quarter worth $185,000. 69.69% of the stock is currently owned by institutional investors.

Aehr Test Systems Stock Performance

Shares of Aehr Test Systems stock opened at $13.86 on Tuesday. The stock has a market capitalization of $412.61 million, a P/E ratio of -106.61 and a beta of 2.29. Aehr Test Systems has a 52-week low of $6.27 and a 52-week high of $21.44. The stock’s 50-day simple moving average is $11.23 and its 200 day simple moving average is $10.72.

Aehr Test Systems (NASDAQ:AEHR) last issued its earnings results on Tuesday, July 8th. The semiconductor company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01. The business had revenue of $14,100 billion for the quarter, compared to analysts’ expectations of $14.83 million. Aehr Test Systems had a negative net margin of 6.63% and a negative return on equity of 0.15%. Equities research analysts forecast that Aehr Test Systems will post 0.1 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Alberto Salamone sold 4,995 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $9.08, for a total value of $45,354.60. Following the transaction, the executive vice president owned 56,241 shares of the company’s stock, valued at $510,668.28. This represents a 8.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 6.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of Aehr Test Systems to a “sell” rating in a research note on Tuesday, May 13th.

Aehr Test Systems Company Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.